688513 Chengdu Easton Biopharmaceuticals Co., Ltd. SSE · China

Chengdu Easton Biopharmaceuticals Co. (688513) news

Chengdu Easton Biopharmaceuticals Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 688513, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Chengdu Easton Biopharmaceuticals Co. news

We have not published a story on Chengdu Easton Biopharmaceuticals Co. yet. When there is news, it will appear here.

Questions about Chengdu Easton Biopharmaceuticals Co.

What is the ticker symbol of Chengdu Easton Biopharmaceuticals Co.?

Chengdu Easton Biopharmaceuticals Co., Ltd. trades under the ticker 688513 on SSE.

Where is Chengdu Easton Biopharmaceuticals Co. listed?

Chengdu Easton Biopharmaceuticals Co., Ltd. is listed on SSE.

Which country or territory is Chengdu Easton Biopharmaceuticals Co. listed under?

Our directory records Chengdu Easton Biopharmaceuticals Co., Ltd. under China.

What does Chengdu Easton Biopharmaceuticals Co. do?

Our directory classifies Chengdu Easton Biopharmaceuticals Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Chengdu Easton Biopharmaceuticals Co.?

The ISIN recorded for Chengdu Easton Biopharmaceuticals Co., Ltd. is CNE100004397.

Does aibio.space cover Chengdu Easton Biopharmaceuticals Co.?

aibio.space lists Chengdu Easton Biopharmaceuticals Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Chengdu Easton Biopharmaceuticals Co.?

Companies in our directory listed in the same country and business area as Chengdu Easton Biopharmaceuticals Co.: Xiamen Kingdomway Group Co., Zhejiang Huakang Pharmaceutical Co., Luoxin Pharmaceuticals Group Stock Co., Zhejiang Anglikang Pharmaceutical Co., Zhejiang Zhenyuan Share Co., Zhejiang Yatai Pharmaceutical Co..

Investor discussion: Chengdu Easton Biopharmaceuticals Co.

Members talk about Chengdu Easton Biopharmaceuticals Co. (688513). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:688513 on TradingView.

Listing details

Company: Chengdu Easton Biopharmaceuticals Co., Ltd.
Ticker: 688513
Listing: SSE
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: CNE100004397
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction